Fulton Bank’s Acceleron Pharma XLRN Stock Holding History

Fulton Bank’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,507	Closed	-$260K	–	550
2021 Q3	$260K	Buy	+1,507	New	+$197K	0.01%	460

Fulton Bank's XLRN Position: Q4 2021 in Review

Fulton Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,507 shares — an estimated $260K sold.

Fulton Bank first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $260K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Fulton Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Fulton Bank sold 1,507 Acceleron Pharma shares in Q4 2021, an estimated $260K.
Fulton Bank first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Fulton Bank's Acceleron Pharma position peaked at $260K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Fulton Bank's 13F filing for Q4 2021, filed 5 Jan 2022.